The goal of this activity is for learners to be better able to understand the pathogenesis of myelofibrosis (MF), the challenges associated with current treatment, and the novel therapies in clinical development aiming to have a positive impact on MF by advancing outcomes and changing the course of the disease.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001540
- Start Date: 2024-09-03 05:00:00
- End Date: 2024-09-03 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Morphosys - Amount: 93551.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest